Steris | STE - Stock


Steris reported $631.8M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
3M USD 3.69B 29M Mar/2026
Accuray USD 150.96M 4.54M Dec/2025
Avanos Medical USD 141.3M 6.7M Mar/2026
Baxter International USD 2.32B 84M Mar/2026
Becton, Dickinson and Co. USD 3.36B 728M Mar/2026
Boston Scientific USD 3.12B 174M Mar/2026
CONMED USD 366.11M 10.56M Mar/2026
Cooper Companies USD 876.4M 30.4M Dec/2025
Dexcom USD 693.6M 64.5M Mar/2026
Ecolab USD 1.57B 81.6M Mar/2026
Edwards Lifesciences USD 1.12B 7.2M Mar/2026
Fortive USD 305.5M 13.7M Mar/2026
Getinge SEK 7.26B 46M Sep/2024
Globus Medical USD 772.6M 13.32M Mar/2026
Haemonetics USD 306.37M 14.82M Mar/2026
Idexx Laboratories USD 382.4M 4.64M Mar/2026
Inogen USD 25.08M 762K Sep/2025
Insulet USD 462.5M 9.9M Mar/2026
Integra LifeSciences USD 495.04M 2.3M Mar/2026
Intuitive Surgical USD 1.95B 105.1M Mar/2026
J&J USD 14.58B 392M Mar/2026
Olympus JPY 208.61B 5.07B Sep/2025
Orthofix International USD 177.82M 5.5M Mar/2026
Owens Minor USD 65.28M 9.15M Mar/2026
ResMed USD 911.88M 10.17M Mar/2026
Steris USD 631.8M 41.7M Mar/2026
Stryker USD 5.42B 109M Mar/2026
Tandem Diabetes Care USD 126.4M 2.37M Mar/2026
Teleflex USD 380.86M 23.53M Mar/2026
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
Zimmer Biomet Holdings USD 2.25B 39.6M Mar/2026